A Stoppacciaro Selected Research

A Stoppacciaro Research Topics

6	Neoplasms (Cancer) 09/2001 - 03/2000
2	Melanoma (Melanoma, Malignant) 09/2001 - 06/2001
2	Papillary Carcinoma 05/2001 - 03/2000
2	Thyroiditis 05/2001 - 12/2000
2	Lymphoma (Lymphomas) 07/2000 - 04/2000
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2010
1	Glomerulonephritis 01/2010
1	Thymoma (Thymic Carcinoma) 09/2007
1	Wounds and Injuries (Trauma) 02/2007
1	Carcinoma (Carcinomatosis) 10/2001
1	Neoplasm Metastasis (Metastasis) 10/2001
1	Thyroid Diseases (Thyroid Disease) 05/2001
1	Adenocarcinoma 01/2001
1	Inflammation (Inflammations) 12/2000
1	Graves Disease (Basedow Disease) 12/2000
1	T-Cell Leukemia (Leukemia, T Cell) 07/2000
1	Carcinogenesis 07/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2000

4	Proteins (Proteins, Gene)FDA Link 09/2001 - 03/2000
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2001 - 01/2001
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2001 - 03/2000
1	Etanercept (Enbrel)FDA Link 01/2010
1	RNA (Ribonucleic Acid)IBA 09/2007
1	CollagenIBA 02/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2007
1	Collagen Type I (Type I Collagen)IBA 02/2007
1	alpha-galactosylceramideIBA 10/2001
1	Interleukin-12 (IL 12)IBA 10/2001
1	Interleukin-8 (Interleukin 8)IBA 09/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2001
1	Angiopoietin-2IBA 09/2001
1	INX 6295IBA 06/2001
1	Cisplatin (Platino)FDA LinkGeneric 06/2001
1	OligodeoxyribonucleotidesIBA 06/2001
1	Liposomes (Liposome)IBA 06/2001
1	LipidsIBA 06/2001
1	ParaffinIBA 05/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2001
1	Indicators and Reagents (Reagents)IBA 05/2001
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2001
1	Drinking WaterIBA 01/2001
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2001
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 12/2000
1	Fas Ligand Protein (Fas Ligand)IBA 12/2000
1	AutoantibodiesIBA 12/2000
1	LigandsIBA 12/2000
1	NF-kappa B (NF-kB)IBA 07/2000
1	NF-KappaB Inhibitor alphaIBA 07/2000
1	Monoclonal AntibodiesIBA 04/2000
1	Biological ProductsIBA 03/2000
1	HLA-DR Antigens (HLA-DR)IBA 03/2000
1	Chemotactic FactorsIBA 03/2000
1	ChemokinesIBA 03/2000
1	InterleukinsIBA 03/2000

1	Therapeutics 01/2001
1	Cell Transplantation 01/2001